buserelin has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atmaca, H; Baybuga, H; Bayram, F; Kelestimur, F; Sahin, Y; Unluhizarci, K | 1 |
| Chlouverakis, CS; Piaditis, GP; Rangou, DB; Spina, J; Stamataki, KE | 1 |
2 other study(ies) available for buserelin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
Topics: Adult; Buserelin; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Premenopause; Prevalence; Sex Hormone-Binding Globulin; Ultrasonography | 2006 |
Ovarian function in women with non-insulin dependent diabetes mellitus.
Topics: Adult; Androstenedione; Buserelin; Diabetes Mellitus, Type 2; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Obesity; Ovary; Testosterone | 1996 |